This article is a retraction of:
RETRACTED: Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy
Frontiers Production OfficeA Retraction of the Review Article
Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy
by Hassanzadeh A, Altajer AH, Rahman HS, Saleh MM, Bokov DO, Abdelbasset WK, Marofi F, Zamani M, Yaghoubi Y, Yazdanifar M, Pathak Y, Chartrand MS and Jarahian M (2021). Front. Cell Dev. Biol. 9:686453. doi: 10.3389/fcell.2021.686453
The journal retracts the 2021 article cited above.
Following publication, concerns were raised regarding the contributions of the authors of the article. Our investigation, conducted in accordance with Frontiers policies, confirmed a serious breach of our authorship policies and of publication ethics; the article is therefore retracted.
This retraction was approved by the Chief Editors of Frontiers in Cell and Developmental Biology and the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy. Front. Cell Dev. Biol. 11:1285267. doi: 10.3389/fcell.2023.1285267
Received: 29 August 2023; Accepted: 29 August 2023;
Published: 04 September 2023.
Approved by:
Amanda Gay Fisher, University of Oxford, United KingdomCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org